Mega Genomics Limited (HKG:6667)

Mega Genomics Statistics

Total Valuation

Mega Genomics has a market cap or net worth of HKD 1.57 billion. The enterprise value is 1.11 billion.

Market Cap	1.57B
Enterprise Value	1.11B

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Mega Genomics has 224.30 million shares outstanding. The number of shares has decreased by -0.61% in one year.

Current Share Class	224.30M
Shares Outstanding	224.30M
Shares Change (YoY)	-0.61%
Shares Change (QoQ)	-2.48%
Owned by Insiders (%)	22.89%
Owned by Institutions (%)	0.00%
Float	119.36M

Valuation Ratios

The trailing PE ratio is 38.56.

PE Ratio	38.56
Forward PE	n/a
PS Ratio	10.35
PB Ratio	2.34
P/TBV Ratio	2.34
P/FCF Ratio	35.21
P/OCF Ratio	35.00
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.51, with an EV/FCF ratio of 24.88.

EV / Earnings	28.62
EV / Sales	7.32
EV / EBITDA	19.51
EV / EBIT	27.30
EV / FCF	24.88

Financial Position

The company has a current ratio of 15.18, with a Debt / Equity ratio of 0.07.

Current Ratio	15.18
Quick Ratio	14.45
Debt / Equity	0.07
Debt / EBITDA	0.77
Debt / FCF	0.98
Interest Coverage	28.27

Financial Efficiency

Return on equity (ROE) is 5.55% and return on invested capital (ROIC) is 15.59%.

Return on Equity (ROE)	5.55%
Return on Assets (ROA)	3.05%
Return on Invested Capital (ROIC)	15.59%
Return on Capital Employed (ROCE)	5.70%
Weighted Average Cost of Capital (WACC)	9.42%
Revenue Per Employee	746,081
Profits Per Employee	190,747
Employee Count	203
Asset Turnover	0.18
Inventory Turnover	8.64

Taxes

In the past 12 months, Mega Genomics has paid 9.20 million in taxes.

Income Tax	9.20M
Effective Tax Rate	19.20%

Stock Price Statistics

The stock price has decreased by -5.80% in the last 52 weeks. The beta is 0.97, so Mega Genomics's price volatility has been similar to the market average.

Beta (5Y)	0.97
52-Week Price Change	-5.80%
50-Day Moving Average	7.74
200-Day Moving Average	8.42
Relative Strength Index (RSI)	44.18
Average Volume (20 Days)	23,120

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mega Genomics had revenue of HKD 151.45 million and earned 38.72 million in profits. Earnings per share was 0.18.

Revenue	151.45M
Gross Profit	120.39M
Operating Income	40.58M
Pretax Income	47.92M
Net Income	38.72M
EBITDA	51.45M
EBIT	40.58M
Earnings Per Share (EPS)	0.18

Balance Sheet

The company has 503.46 million in cash and 43.67 million in debt, with a net cash position of 459.78 million or 2.05 per share.

Cash & Cash Equivalents	503.46M
Total Debt	43.67M
Net Cash	459.78M
Net Cash Per Share	2.05
Equity (Book Value)	670.18M
Book Value Per Share	2.99
Working Capital	592.93M

Cash Flow

In the last 12 months, operating cash flow was 44.80 million and capital expenditures -271,753, giving a free cash flow of 44.53 million.

Operating Cash Flow	44.80M
Capital Expenditures	-271,753
Free Cash Flow	44.53M
FCF Per Share	0.20

Margins

Gross margin is 79.49%, with operating and profit margins of 26.80% and 25.57%.

Gross Margin	79.49%
Operating Margin	26.80%
Pretax Margin	31.64%
Profit Margin	25.57%
EBITDA Margin	33.97%
EBIT Margin	26.80%
FCF Margin	29.40%

Dividends & Yields

Mega Genomics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.61%
Shareholder Yield	0.61%
Earnings Yield	2.47%
FCF Yield	2.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Mega Genomics has an Altman Z-Score of 15.81 and a Piotroski F-Score of 7.

Altman Z-Score	15.81
Piotroski F-Score	7